Dai Lingyan, Jiang Chunxiang, Cui Qingmei, Huang Leen, Chen Siqi, Zhang Yidan, Luo Xiaoyi, Zhang Piao, Li Jie, Zhang Yuhu
Global Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
J Prev Alzheimers Dis. 2025 Jan;12(1):100020. doi: 10.1016/j.tjpad.2024.100020. Epub 2025 Jan 1.
While optimal cardiovascular health (CVH) has been linked to a lower risk of dementia, few studies considered individuals' genetic background. We aimed to examine the interaction between CVH and genetic predisposition on dementia risk among individuals with atherosclerotic cardiovascular disease (ASCVD).
We included 30,818 ASCVD patients from the UK Biobank. CVH was assessed using Life's Essential 8, and genetic predisposition determined by a genetic risk score (GRS) incorporating 85 genetic variants. Cox proportional hazard models were used to estimate hazard ratios (HRs) for all-cause dementia, Alzheimer's disease (AD), and vascular dementia (VaD).
Over a median follow-up of 13.5 years, 1,360 cases of all-cause dementia were identified, including 489 AD and 440 VaD cases. Higher CVH levels were associated with a reduced risk of all-cause dementia (HR for high vs. low CVH: 0.60; 95 % CI: 0.47-0.77) and VaD (HR for high vs. low CVH: 0.32; 95 % CI: 0.19-0.54), with a stronger association in individuals with lower GRS. Although the overall CVH score was not associated with the risk of dementia in individuals with high GRS, higher levels of sleep and glucose control were associated with a lower risk of VaD. CVH levels showed no association with the risk of AD.
Higher CVH levels were associated with a lower risk of VaD, not AD, with a stronger association in individuals with low GRS. Improvements in specific LE8 components, particularly sleep health and blood glucose management, were associated with reduced VaD risk across various genetic risk strata.
虽然最佳心血管健康(CVH)与较低的痴呆风险相关,但很少有研究考虑个体的遗传背景。我们旨在研究CVH与遗传易感性在动脉粥样硬化性心血管疾病(ASCVD)患者痴呆风险中的相互作用。
我们纳入了英国生物银行的30818例ASCVD患者。使用生命基本8项指标评估CVH,并通过包含85个基因变异的遗传风险评分(GRS)确定遗传易感性。采用Cox比例风险模型估计全因痴呆、阿尔茨海默病(AD)和血管性痴呆(VaD)的风险比(HR)。
在中位随访13.5年期间,共识别出1360例全因痴呆病例,包括489例AD和440例VaD病例。较高的CVH水平与全因痴呆(高CVH与低CVH的HR:0.60;95%CI:0.47-0.77)和VaD(高CVH与低CVH的HR:0.32;95%CI:0.19-0.54)风险降低相关,在GRS较低的个体中关联更强。虽然总体CVH评分与GRS较高个体的痴呆风险无关,但较高的睡眠和血糖控制水平与较低的VaD风险相关。CVH水平与AD风险无关。
较高的CVH水平与较低的VaD风险相关,而非AD,在GRS较低的个体中关联更强。特定生命基本8项指标成分的改善,尤其是睡眠健康和血糖管理,与不同遗传风险分层中VaD风险降低相关。